|1.||Eriksson, Hans: 31 articles (05/2015 - 03/2009)|
|2.||Vieta, Eduard: 27 articles (02/2014 - 10/2002)|
|3.||Brecher, Martin: 26 articles (05/2010 - 07/2003)|
|4.||Calabrese, Joseph R: 23 articles (10/2015 - 11/2004)|
|5.||Paulsson, Björn: 20 articles (02/2014 - 12/2004)|
|6.||Citrome, Leslie: 19 articles (12/2014 - 09/2004)|
|7.||Li, Xin-Min: 18 articles (02/2015 - 11/2005)|
|8.||McIntyre, Roger S: 17 articles (12/2015 - 11/2003)|
|9.||Ketter, Terence A: 16 articles (05/2015 - 07/2005)|
|10.||Leucht, Stefan: 16 articles (01/2014 - 04/2007)|
|1.||Schizophrenia (Dementia Praecox)
04/01/1999 - "From these results, quetiapine fumarate was suggested to be highly effective and safe for the treatment of schizophrenia."
04/01/2007 - "The efficacy of quetiapine in reducing positive and negative symptoms of schizophrenia has been proven in several clinical trials with placebo-controlled comparators. "
01/01/2011 - "Quetiapine is an atypical antipsychotic with proven efficacy and an established tolerability profile in schizophrenia. "
07/01/2003 - "Quetiapine, an atypical antipsychotic with proven efficacy in the treatment of psychotic symptoms in schizophrenia, also has efficacy for treating depressive symptoms in patients with schizophrenia and other psychiatric disorders. "
10/01/2001 - "Quetiapine is a novel atypical antipsychotic with proven efficacy in schizophrenia across all domains. "
|2.||Bipolar Disorder (Mania)
01/01/2007 - "Quetiapine as monotherapy, or in combination with Li or DVP, was a highly effective treatment for acute mania, as shown by overall change scores in the total YMRS. "
01/01/2007 - "Quetiapine was associated with significantly higher response and remission/euthymia rates compared with placebo with most criteria used, in patients with acute mania at the end of both 3 and 12 weeks."
01/01/2012 - "In bipolar disorder, quetiapine XR has also proven effective in relieving acute depressive and manic symptoms. "
12/01/2008 - "Quetiapine monotherapy is effective in improving impairment in important aspects of life that accompany improvements in depressive symptoms in patients with acute bipolar depression."
01/01/2013 - "In this 3-week study, quetiapine was significantly more effective than placebo in improving manic symptoms in youth with mania associated with bipolar disorder. "
|3.||Psychotic Disorders (Schizoaffective Disorder)
10/01/2004 - "The administration of quetiapine in doses of 25-50 mg/day brought about an important improvement in the control over the signs of parkinsonian psychoses in our patients. "
01/01/2001 - "Quetiapine is suggested to be effective treatment of youths with psychotic disorders and to have a favorable side-effect profile."
01/01/2007 - "In line with other studies, quetiapine may be considered as an effective treatment for adolescents with a severe psychotic disorder showing a favourable side-effect profile. "
04/01/2000 - "This is the first investigation of the pharmacokinetics, tolerability, and efficacy of quetiapine fumarate in adolescents with chronic or intermittent psychotic disorders. "
04/01/2015 - "The atypical antipsychotic quetiapine has been used in different psychotic and non-psychotic disorders in children and adolescents in randomized clinical trials, open-label studies and chart reviews. "
|4.||Sleep Initiation and Maintenance Disorders (Insomnia)
06/01/2014 - "A time × drug interaction was seen for the subjective insomnia, such that quetiapine XR-treated subjects reported greater initial improvement in their subjective insomnia, but the difference was not sustained. "
01/01/2009 - "Quetiapine has been demonstrated in open-label trials to be effective for the treatment of insomnia and VH in PD. "
12/01/2006 - "As the studied patients with depression showed improvement in subjective and objective sleep parameters, quetiapine may be a promising drug for patients with depression and insomnia. "
07/01/2005 - "These results suggest that quetiapine may be a safe and effective treatment of insomnia in PD patients. "
03/01/2014 - "Robust studies evaluating the safety and efficacy of quetiapine for the treatment of insomnia are lacking. "
|5.||Major Depressive Disorder (Major Depressive Disorders)
12/01/2009 - "Taken together, extant studies demonstrated that quetiapine XR (50 - 300 mg) provides rapid and sustained symptomatic improvement in the acute and maintenance treatment of major depressive disorder. "
01/01/2012 - "Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies."
12/01/2015 - "The aim of this post-hoc analysis was to determine whether early symptom improvement with extended release quetiapine (quetiapine XR) may predict treatment outcome in patients with major depressive disorder. "
05/01/2015 - "Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder."
05/01/2013 - "The efficacy of quetiapine XR was investigated in patients with major depressive disorder and differing levels of baseline severity. "
|2.||Antipsychotic Agents (Antipsychotics)
|3.||Risperidone (Risperdal Consta)
|10.||Valproic Acid (Valproate, Semisodium)
|2.||Drug Therapy (Chemotherapy)
|5.||Length of Stay